iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum
NASHUA, N.H.,
Nov. 18, 2019 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that Michael Klein, Chairman and Chief Executive Officer, will
present a corporate overview at the Canaccord Genuity MedTech & Diagnostics
Forum, taking place Thursday, November 21st in New York City.
Presentation | |
Date: | Thursday, November 21, 2019 |
Time: | 10:00am Eastern Time |
Webcast: | |
About
iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader
providing innovative cancer detection and therapy solutions. For more
information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com